Home260660 • KOSDAQ
add
Korea Arlico Pharm Co Ltd
Previous close
₩3,820.00
Year range
₩3,070.00 - ₩6,130.00
Market cap
58.55B KRW
Avg Volume
43.42K
P/E ratio
-
Dividend yield
1.96%
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 52.20B | 6.93% |
Operating expense | 26.17B | 3.99% |
Net income | -553.75M | -151.30% |
Net profit margin | -1.06 | -147.96% |
Earnings per share | — | — |
EBITDA | 1.19B | -59.58% |
Effective tax rate | -55.15% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.61B | 23.70% |
Total assets | 173.73B | 5.79% |
Total liabilities | 94.67B | 17.51% |
Total equity | 79.06B | — |
Shares outstanding | 14.97M | — |
Price to book | 0.72 | — |
Return on assets | 0.01% | — |
Return on capital | 0.01% | — |
Cash Flow
Net change in cash
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -553.75M | -151.30% |
Cash from operations | 2.15B | 504.00% |
Cash from investing | -1.57B | -177.25% |
Cash from financing | -20.48M | 99.02% |
Net change in cash | 578.13M | 185.54% |
Free cash flow | 3.24B | 256.43% |
About
Founded
1992
Website
Employees
230
